von Hahn T - Search Results

1

Anti-retroviral drugs do not facilitate hepatitis C virus (HCV) infection in vitro.

Sandmann L, Wilson M, Back D, Wedemeyer H, Manns MP, Steinmann E, Pietschmann T, von Hahn T, Ciesek S. Sandmann L, et al. Among authors: von hahn t. Antiviral Res. 2012 Oct;96(1):51-8. doi: 10.1016/j.antiviral.2012.07.005. Epub 2012 Jul 24. Antiviral Res. 2012. PMID: 22842003

2

Cyclosporine A inhibits hepatitis C virus nonstructural protein 2 through cyclophilin A.

Ciesek S, Steinmann E, Wedemeyer H, Manns MP, Neyts J, Tautz N, Madan V, Bartenschlager R, von Hahn T, Pietschmann T. Ciesek S, et al. Among authors: von hahn t. Hepatology. 2009 Nov;50(5):1638-45. doi: 10.1002/hep.23281. Hepatology. 2009. PMID: 19821520

3

Know your enemy: translating insights about the molecular biology of hepatitis C virus into novel therapeutic approaches.

von Hahn T, Steinmann E, Ciesek S, Pietschmann T. von Hahn T, et al. Expert Rev Gastroenterol Hepatol. 2010 Feb;4(1):63-79. doi: 10.1586/egh.09.74. Expert Rev Gastroenterol Hepatol. 2010. PMID: 20136590 Review.

4

Impact of intra- and interspecies variation of occludin on its function as coreceptor for authentic hepatitis C virus particles.

Ciesek S, Westhaus S, Wicht M, Wappler I, Henschen S, Sarrazin C, Hamdi N, Abdelaziz AI, Strassburg CP, Wedemeyer H, Manns MP, Pietschmann T, von Hahn T. Ciesek S, et al. Among authors: von hahn t. J Virol. 2011 Aug;85(15):7613-21. doi: 10.1128/JVI.00212-11. Epub 2011 Jun 1. J Virol. 2011. PMID: 21632765 Free PMC article.

5

Epidemiological trends in incidence and mortality of hepatobiliary cancers in Germany.

von Hahn T, Ciesek S, Wegener G, Plentz RR, Weismüller TJ, Wedemeyer H, Manns MP, Greten TF, Malek NP. von Hahn T, et al. Scand J Gastroenterol. 2011 Sep;46(9):1092-8. doi: 10.3109/00365521.2011.589472. Epub 2011 Jun 22. Scand J Gastroenterol. 2011. PMID: 21692710

6

The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry.

Ciesek S, von Hahn T, Colpitts CC, Schang LM, Friesland M, Steinmann J, Manns MP, Ott M, Wedemeyer H, Meuleman P, Pietschmann T, Steinmann E. Ciesek S, et al. Among authors: von hahn t. Hepatology. 2011 Dec;54(6):1947-55. doi: 10.1002/hep.24610. Hepatology. 2011. PMID: 21837753

7

Second-wave protease inhibitors: choosing an heir.

Ciesek S, von Hahn T, Manns MP. Ciesek S, et al. Among authors: von hahn t. Clin Liver Dis. 2011 Aug;15(3):597-609. doi: 10.1016/j.cld.2011.05.014. Epub 2011 Jun 25. Clin Liver Dis. 2011. PMID: 21867939 Review.

8

The novel immunosuppressive protein kinase C inhibitor sotrastaurin has no pro-viral effects on the replication cycle of hepatitis B or C virus.

von Hahn T, Schulze A, Chicano Wust I, Heidrich B, Becker T, Steinmann E, Helfritz FA, Rohrmann K, Urban S, Manns MP, Pietschmann T, Ciesek S. von Hahn T, et al. PLoS One. 2011;6(9):e24142. doi: 10.1371/journal.pone.0024142. Epub 2011 Sep 1. PLoS One. 2011. PMID: 21909416 Free PMC article.

9

Arrest all accessories--inhibition of hepatitis C virus by compounds that target host factors.

von Hahn T, Ciesek S, Manns MP. von Hahn T, et al. Discov Med. 2011 Sep;12(64):237-44. Discov Med. 2011. PMID: 21955851 Free article. Review.

10

Hepatocytes that express variants of cyclophilin A are resistant to HCV infection and replication.

von Hahn T, Schiene-Fischer C, Van ND, Pfaender S, Karavul B, Steinmann E, Potthoff A, Strassburg C, Hamdi N, Abdelaziz AI, Sarrazin C, Müller T, Berg T, Trépo E, Wedemeyer H, Manns MP, Pietschmann T, Ciesek S. von Hahn T, et al. Gastroenterology. 2012 Aug;143(2):439-47.e1. doi: 10.1053/j.gastro.2012.04.053. Epub 2012 May 8. Gastroenterology. 2012. PMID: 22580540

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

91 results

Search Page

Filters